p53による転写活性化は,成長抑制と相関するが,変換抑制とは相関しない
T Crook1, N J Marston, E A Sara
1Ludwig Institute for Cancer Research, St. Mary's Hospital Medical School, London, England.
Cell
|December 2, 1994
まとめ
変異した腫瘍抑制タンパク質p53 (p53) は,腫瘍抑制能力を失う可能性があります. いくつかのp53変異体が転写を活性化し,成長を抑制する一方で,他の変異を促すこともあり,転写活動が必ずしも腫瘍抑制を保証するものではないことを示しています.
科学分野:
- 分子生物学は分子生物学である.
- がん研究 がん研究
- 腫瘍抑制遺伝子は,腫瘍を抑制する遺伝子です.
背景:
- 腫瘍抑制タンパク質p53は,がんの予防に不可欠です.
- p53の変異は,様々ながんにおいて一般的であり,腫瘍抑制機能の喪失につながる.
- p53変異の機能的影響を理解することは,がん治療に不可欠です.
研究 の 目的:
- 転写活性化とp53変異体による成長/変異抑制の相関を調査する.
- すべての転写活性p53変異体が腫瘍形成を抑制できるかどうかを判断する.
- 特定のp53変異体が変異を促進するメカニズムを探求する.
主な方法:
- ヒトのp53-null細胞におけるp53変異体の大きなシリーズの分析.
- p53変異体の転写活性化および成長抑制機能を評価する.
- 主要歯類の細胞における変換抑制を評価する.
- ミュータントp53.3によるトランスドミナント抑制の役割を調査
主要な成果:
- 転写活性化とp53-nullヒト細胞の成長抑制の間に強い相関が観察されました.
- 転写的に活発なp53変異種がすべて,歯類の原始細胞における変異を抑制する能力を保持しているわけではない.
- 腫瘍に由来する2つの特定のp53変異体が,変換活動とトランザクティベーション活動の両方を示した.
- これらの変異体による変異は,内生的なp53機能のトランスドミナント抑制とは無関係であり,p53の転写活性が上昇したことが観察されました.
結論:
- p53変異体による転写活性化は,必ずしも腫瘍抑制につながらない.
- 特定のp53変異体は,転写活性を保持しているにもかかわらず,腫瘍性潜在能力を有することがあります.
- この発見は,がんの発生と進行におけるp53変異の複雑な役割を強調しています.
関連する概念動画
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


